Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
    April 2023
  1. FERIOLI M, Ferrari M, Galasso T, Natali F, et al
    A 60-Year-Old Man With a Migratory Lobar Consolidation After Invasive Ventilation.
    Chest. 2023;163:e163-e166.
    >> Share

  2. KIM JY, Lee HW, Yim JJ, Kwak N, et al
    Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis.
    Chest. 2023;163:763-777.
    >> Share

    February 2023
  3. YAN M, Brode SK, Marras TK
    The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
    Chest. 2023;163:281-291.
    >> Share

    January 2023
  4. WONG C, Martinez-Garcia MA
    Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?
    Chest. 2023;163:3-5.
    >> Share

    November 2022
  5. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    >> Share

  6. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    >> Share

  7. LEE S, Lee HW, Kim HJ, Kim DK, et al
    Deep Learning-Based Prediction Model Using Radiography in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:995-1005.
    >> Share

    October 2022
  8. PAN SW, Shu CC
    Time to Consider Treatment Initiation for Patients With Nontuberculous Mycobacterial Lung Disease.
    Chest. 2022;162:e203-e204.
    >> Share

  9. HENDERSON K, Bilancia R, Choo-Kang B, Maclay J, et al
    An Unusual Case of Postpartum Empyema.
    Chest. 2022;162:e157-e159.
    >> Share

    September 2022
  10. DESHMUKH S, Sane M, Gaikwad S, Sahasrabudhe T, et al
    Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in India.
    Chest. 2022 Sep 26. pii: S0012-3692(22)03893-4. doi: 10.1016/j.chest.2022.
    >> Share

  11. KIM Y, Yoon JH, Ryu J, Yang B, et al
    Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease.
    Chest. 2022 Sep 7. pii: S0012-3692(22)03704-7. doi: 10.1016/j.chest.2022.08.2228
    >> Share

    August 2022
  12. BLANC PD, Balmes JR, Redlich C
    Occupational Exposures in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:e106-e107.
    >> Share

    July 2022
  13. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    >> Share

  14. BARKER H, Chen C
    Pandemic Outbreaks and the Language of Violence: Discussing the Origins of the Black Death and COVID-19.
    Chest. 2022;162:196-201.
    >> Share

  15. GREEN HD, Jones AM
    Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series.
    Chest. 2022;162:66-75.
    >> Share

  16. HENRIETTE ZWEIJPFENNING SM, Chiron R, Essink S, Schildkraut J, et al
    Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
    Chest. 2022;162:76-81.
    >> Share

    May 2022
  17. CHOTIRMALL SH, Aliberti S
    Leveraging the Omics Revolution for Nontuberculous Mycobacteria Biomarkers.
    Chest. 2022;161:1129-1131.
    >> Share

  18. IM Y, Hwang NY, Kim K, Kim H, et al
    Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.
    Chest. 2022;161:1192-1200.
    >> Share

  19. PARK JW, Curtis JR, Jun KI, Kim TM, et al
    Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.
    Chest. 2022;161:1201-1210.
    >> Share

    April 2022
  20. MA X, Yu D, Jie B, Li LL, et al
    Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined with Pulmonary Tuberculosis.
    Chest. 2022 Apr 28. pii: S0012-3692(22)00880-7. doi: 10.1016/j.chest.2022.
    >> Share

  21. JUNG HI, Kim SA, Kim HJ, Yim JJ, et al
    Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study in South Korea.
    Chest. 2022;161:918-926.
    >> Share

    March 2022
  22. KUMAR K, Loebinger MR
    Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series.
    Chest. 2022;161:637-646.
    >> Share

    February 2022
  23. LAU A, Lin C, Barrie J, Winter C, et al
    Chest. 2022 Feb 2. pii: S0012-3692(22)00214-8. doi: 10.1016/j.chest.2022.
    >> Share

  24. DANHO R, Schildkraut JA, Zweijpfenning SMH, Svensson EM, et al
    Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2022;161:370-372.
    >> Share

  25. KU JH, Siegel SAR, Philley J, Schipper P, et al
    Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States.
    Chest. 2022;161:365-369.
    >> Share

    January 2022
  26. MELCHERS M, Festen B, den Dekker BM, Mooren ERM, et al
    A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest. 2022;161:e5-e11.
    >> Share

  27. GRIFFITH DE, Daley CL
    Introducing the Nontuberculous Mycobacteria Series for CHEST.
    Chest. 2022;161:1-2.
    >> Share

    POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes.
    Chest. 2022;161:18-20.
    >> Share

  29. GRIFFITH DE, Daley CL
    Treatment of Mycobacterium abscessus Pulmonary Disease.
    Chest. 2022;161:64-75.
    >> Share

    December 2021
  30. MASKIN LP, Garcia Hernandez MH, Stryjewski ME, Rodriguez PO, et al
    A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules.
    Chest. 2021;160:e639-e643.
    >> Share

  31. TASHIRO H, Takahashi K, Haraguchi T, Jinnouchi K, et al
    A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction.
    Chest. 2021;160:e623-e628.
    >> Share

  32. JONES TPW, Dabbaj S, Mandal I, Cleverley J, et al
    The Blood Neutrophil Count After 1 Month of Treatment Predicts the Radiologic Severity of Lung Disease at Treatment End.
    Chest. 2021;160:2030-2041.
    >> Share

  33. PREVOTS DR, Marras TK, Wang P, Mange KC, et al
    Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2021;160:2042-2050.
    >> Share

    November 2021
  34. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    >> Share

  35. CORREA LF, Fritscher CC, Fritscher RT, da Silva TKB, et al
    Exclusively Tracheobronchial Paracoccidioidomycosis: A Rare Presentation.
    Chest. 2021;160:e499-e501.
    >> Share

  36. ZUPETIC J, Penaloza HF, Bain W, Hulver M, et al
    Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.
    Chest. 2021;160:1624-1633.
    >> Share

    October 2021
  37. THOMAS-RUDDEL D, Schlattmann P, Pletz M, Kurzai O, et al
    Risk factors for invasive candida infection in critically ill patients - a systematic review and meta-analysis.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04112-X. doi: 10.1016/j.chest.2021.
    >> Share

  38. HERBERTS MB, Johnson TF, Escalante P
    A 70-Year-Old Man With Cough and Recurrent Respiratory Infections.
    Chest. 2021;160:e347-e350.
    >> Share

  39. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    >> Share

  40. MUMMADI SR, Stoller JK, Lopez R, Kailasam K, et al
    Epidemiology of Adult Pleural Disease in the United States.
    Chest. 2021;160:1534-1551.
    >> Share

    September 2021
  41. GRIFFITH DE, Thomson R, Flume PA, Aksamit TR, et al
    Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
    Chest. 2021;160:831-842.
    >> Share

    August 2021
  42. SAHA BK, Chong W
    A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
    Chest. 2021;160:e181-e184.
    >> Share

  43. YU Q, Zhang Q, Yu J, Song Y, et al
    A 66-Year-Old Woman With Progressive Dyspnea and Obstructive Pneumonia.
    Chest. 2021;160:e177-e180.
    >> Share

  44. KANG N, Jeon K, Kim H, Kwon OJ, et al
    Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Chest. 2021;160:436-445.
    >> Share

    July 2021
  45. AKSAMIT TR, Marras TK
    Clofazimine Drug Susceptibility Testing for Nontuberculous Mycobacteria: A Call to Arms.
    Chest. 2021;160:e90.
    >> Share

    June 2021
  46. BARROS AJ, Enfield KB, Kadl A
    Intraarterial Catheter Use Is Associated With Increased Risk of Hospital Onset Bacteremia: A Retrospective Cohort Study.
    Chest. 2021;159:2321-2324.
    >> Share

  47. GHEYATH B, Akram A, Gong R, Tovar J, et al
    A 70-Year-Old Man With Conspicuous Thigh Pain and ST-Segment Elevations.
    Chest. 2021;159:e403-e407.
    >> Share

  48. HAWES AM, Chou C, Co I
    An 80-Year-Old Man With Persistent Enterococcus faecalis Bacteremia.
    Chest. 2021;159:e377-e380.
    >> Share

  49. WEINGART MF, Li Q, Choi S, Maleki-Fischbach M, et al
    Analysis of Non-TB Mycobacterial Lung Disease in Patients With Primary Sjogren's Syndrome at a Referral Center.
    Chest. 2021;159:2218-2221.
    >> Share

    May 2021
  50. MCCALLUM GB, Oguoma VM, Versteegh LA, Wilson CA, et al
    Comparison of First Nations and non-First Nations children's profiles with bronchiectasis over two five-year periods from the Northern Territory, Australia.
    Chest. 2021 May 5. pii: S0012-3692(21)00865-5. doi: 10.1016/j.chest.2021.
    >> Share

  51. NADA KM, Nishi S, Duarte A
    Pneumonia and Poorly Controlled Diabetes.
    Chest. 2021;159:e343-e347.
    >> Share

  52. ALLGAIER J, Lagu T, Haessler S, Imrey PB, et al
    Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample.
    Chest. 2021;159:1782-1792.
    >> Share

    April 2021
  53. SEHGAL IS, Basumatary NM, Dhooria S, Prasad KT, et al
    A randomized trial of Mycobacterium w in severe presumed Gram-negative sepsis (MIST).
    Chest. 2021 Apr 11. pii: S0012-3692(21)00680-2. doi: 10.1016/j.chest.2021.
    >> Share

  54. GRIFFITH DE, Aksamit TR
    Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
    Chest. 2021;159:1372-1381.
    >> Share

    March 2021
  55. RHEDIN S, Lundholm C, Osvald EC, Almqvist C, et al
    Pneumonia in infancy and risk for asthma - the role of familial confounding and pneumococcal vaccination.
    Chest. 2021 Mar 13. pii: S0012-3692(21)00480-3. doi: 10.1016/j.chest.2021.
    >> Share

    February 2021
  56. METERSKY ML, Choate R
    The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients with Bronchiectasis.
    Chest. 2021 Feb 19. pii: S0012-3692(21)00283-X. doi: 10.1016/j.chest.2021.
    >> Share

    December 2020
  57. YANG B, Ryu J, Kim T, Jo YS, et al
    Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study.
    Chest. 2020 Dec 26. pii: S0012-3692(20)35503-3. doi: 10.1016/j.chest.2020.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016